Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Active, not recruiting · NCT06334133 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 3 | 2026-07-28 | NCT06334133 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| vTv Therapeutics | 2 |
52 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.